FindTrial
Sign In

Cognitive adverse effects of anti-epileptic drugs investigated using fMRI

Cognitive adverse effects of anti-epileptic drugs investigated using fMRI - Cognitive adverse effects of AEDs investigated using fMRI

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35526
Enrollment
50
Registered
2010-04-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

convulsions epilepsy

Interventions

None listed

Sponsors

Epilepsiecentrum Kempenhaeghe
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age over 18 years old, able to give informed consent, using anti-epileptic drugs when investigations take place.

Exclusion criteria

Exclusion criteria: Absolute or relative contra-indications for MR scanning, unable to peform tasks in MR or unable to complete the questionnaires.

Design outcomes

Primary

MeasureTime frame
Main study parameters/endpoints: Network describing MR parameters, especially fMRI and functional connectivity; Relations between these parameters and changes in anti-epileptic drugs used.—

Secondary

MeasureTime frame
The MR parameters and anti-epileptic drug use will be correlated with neuropsychological test results.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)